As of 2024-12-12, the Relative Valuation of ImmuPharma PLC (IMM.L) is (9.84) GBP. This relative valuation is based on P/E multiples. With the latest stock price at 1.13 GBP, the upside of ImmuPharma PLC based on Relative Valuation is -972.9%.
The range of the Relative Valuation is (10.15) - (11.89) GBP.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 12.4x - 16.1x | 13.9x |
| Forward P/E multiples | 10.0x - 14.5x | 10.1x |
| Fair Price | (10.15) - (11.89) | (9.84) |
| Upside | -1000.5% - -1154.7% | -972.9% |
| Date | P/E |
| 2024-11-26 | -1.89 |
| 2024-11-25 | -1.82 |
| 2024-11-22 | -1.91 |
| 2024-11-21 | -1.91 |
| 2024-11-20 | -1.94 |
| 2024-11-19 | -1.98 |
| 2024-11-18 | -2.01 |
| 2024-11-15 | -2.05 |
| 2024-11-14 | -2.02 |
| 2024-11-13 | -2.02 |
| 2024-11-12 | -2.02 |
| 2024-11-11 | -2.01 |
| 2024-11-08 | -2.02 |
| 2024-11-07 | -2.05 |
| 2024-11-06 | -2.00 |
| 2024-11-05 | -1.99 |
| 2024-11-04 | -1.92 |
| 2024-11-01 | -1.90 |
| 2024-10-31 | -1.94 |
| 2024-10-30 | -1.90 |
| 2024-10-29 | -1.89 |
| 2024-10-28 | -2.18 |
| 2024-10-25 | -2.08 |
| 2024-10-24 | -2.22 |
| 2024-10-23 | -2.23 |
| 2024-10-22 | -2.36 |
| 2024-10-21 | -2.37 |
| 2024-10-18 | -2.36 |
| 2024-10-17 | -2.37 |
| 2024-10-16 | -2.38 |
| 2024-10-15 | -2.36 |
| 2024-10-14 | -2.36 |
| 2024-10-11 | -2.35 |
| 2024-10-10 | -2.33 |
| 2024-10-09 | -2.32 |
| 2024-10-08 | -2.30 |
| 2024-10-07 | -2.32 |
| 2024-10-04 | -2.27 |
| 2024-10-03 | -2.27 |
| 2024-10-02 | -2.27 |
| 2024-10-01 | -2.23 |
| 2024-09-30 | -2.21 |
| 2024-09-27 | -2.19 |
| 2024-09-26 | -2.24 |
| 2024-09-25 | -2.23 |
| 2024-09-24 | -2.20 |
| 2024-09-23 | -2.16 |
| 2024-09-20 | -2.16 |
| 2024-09-19 | -2.10 |
| 2024-09-18 | -2.06 |